Akoya Biosciences Inc (AKYA)

Sector:
INFORMATION TECHNOLOGY
Industry:
ELECTRONIC EQUIPMENT
SIC:
CEO:
Brian McKelligon
Employees:
90
100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH, MA 01762
855.896.8401

Akoya Biosciences provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 240.435 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.2
Price to Revenue7.5024 Debt to Equity0.4765 EBITDA-53.611 Million
Price to Book Value5.32 Operating Margin-92.175 Enterprise Value438.998 Million
Current Ratio3.549 EPS Growth1.134 Quick Ratio2.903
1 Yr BETA 1.4349 52-week High/Low 16.57 / 8.02 Profit Margin-98.0783
Operating Cash Flow Growth-144.2142 Altman Z-Score1.9529 Free Cash Flow to Firm -43.157 Million
Earnings Report2022-11-08
View SEC Filings from AKYA instead.

View recent insider trading info

Akoya Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AKYA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AKYA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

37.3 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOLAN GARRY PH.D.

  • Director
 622,788 2022-09-14 4

MCKELLIGON BRIAN PRESIDENT/CEO

  • Officer
 423,129 2022-09-07 3

SHEPLER ROBERT G

  • Director
 280,141 2022-06-01 2

LAI GOLDMAN MYLA

  • Director
 30,549 2022-06-01 1

SCHNETTLER THOMAS P

  • Director
 2,844,320 2022-06-01 1

RAFFIN THOMAS A.

  • Director
 15,910,388 2022-06-01 1

MENDEL SCOTT

  • Director
 39,049 2022-06-01 2

WINKLER MATTHEW

  • Director
 811,674 2022-06-01 1

EL-GABRY EHAB CHIEF MEDICAL OFFICER

  • Officer
 150,000 2022-05-19 2

RAMACHANDRAN NIRO PH.D CHIEF BUSINESS OFFICER

  • Officer
 219,246 2022-04-13 3

DRISCOLL JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
 37,500 2022-03-23 1

PLA FREDERIC CHIEF OPERATING OFFICER

  • Officer
 67,500 2022-03-23 1

MOY MARILEE CHIEF PEOPLE OFFICER

  • Officer
 120,000 2022-02-24 2

RAFFIN THOMAS A.

MACKOWSKI J MATTHEW

LASHKARI DEVAL

TELEGRAPH HILL PARTNERS III, L.P.

THP III AFFILIATES FUND, LLC

TELEGRAPH HILL PARTNERS III INVESTMENT MANAGEMENT, LLC

TELEGRAPH HILL PARTNERS MANAGEMENT COMPANY, LLC

  • Director
  • 10% Owner
 16,104,431 2021-04-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NOLAN GARRY PH.D. - Director

2022-09-16 19:07:43 -0400 2022-09-14 S 8,305 $13.26 d 622,788 direct -3.4483 -10.5971 0.0 1 -10.5971 6

NOLAN GARRY PH.D. - Director

2022-09-13 16:07:45 -0400 2022-09-12 S 1,800 $13.30 d 631,093 direct 0.7048 -10.2584 0.7048 2 -10.2584 6

NOLAN GARRY PH.D. - Director

2022-09-13 16:07:45 -0400 2022-09-09 S 22,191 $13.31 d 632,893 direct 0.7048 -10.2584 0.7048 2 -10.2584 6

MCKELLIGON BRIAN - Officer PRESIDENT/CEO

2022-09-09 16:00:55 -0400 2022-09-07 M 5,000 $0.30 a 85,000 direct -2.9186 -8.679 0.0 1 -8.679 6

MCKELLIGON BRIAN - Officer PRESIDENT/CEO

2022-09-09 16:00:55 -0400 2022-09-07 S 5,000 $12.83 d 80,000 direct yes -2.9186 -8.679 0.0 1 -8.679 6

MCKELLIGON BRIAN - Officer PRESIDENT/CEO

2022-09-09 16:00:55 -0400 2022-09-07 M 5,000 d 343,129 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AKOYA BIOSCIENCES INC AKYA 2022-10-04 22:15:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 21:45:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 21:15:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 20:45:04 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 20:15:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 19:45:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 19:15:04 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 18:45:04 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 18:15:04 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 17:45:04 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 17:15:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 16:45:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 16:15:04 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 15:45:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 15:15:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 14:45:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 14:15:03 UTC 1.3733 1.6967 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 13:45:03 UTC 1.3622 1.7078 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 13:15:04 UTC 1.3622 1.7078 45000
AKOYA BIOSCIENCES INC AKYA 2022-10-04 12:45:03 UTC 1.3622 1.7078 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AKYA -900.0 shares, $-11565.0 2022-06-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments